| | |
ESBL(−)
|
ESBL(+)
|
P-value
|
|---|
| |
Integron(−)
|
Integron(+)
| | |
Integron(−)
|
Integron(+)
| | |
|---|
| | |
Total
|
N
|
%
|
N
|
%
|
P-value
|
Total
|
N
|
%
|
N
|
%
|
P-value
| |
|---|
|
Sex
|
Male
|
29
|
9
|
31.0
|
20
|
69.0
|
0.851
|
8
|
2
|
25.0
|
6
|
75.0
|
1.000
|
1.000
|
|
Female
|
21
|
6
|
28.6
|
15
|
71.4
| |
12
|
4
|
33.3
|
8
|
66.7
| |
1.000
|
|
Previous antibiotics at the empirical stage before
|
No
|
24
|
1
|
5.0
|
23
|
95.0
|
1.000
|
17
|
7
|
41.2
|
10
|
58.8
|
1.000
|
0.023
|
|
E. cloacae infection
|
Yes
|
26
|
16
|
61.0
|
10
|
39.0
| |
3
|
1
|
33.3
|
2
|
66.7
| | |
|
Prognosis
|
Survival
|
38
|
18
|
47.4
|
20
|
52.6
|
0.874
|
8
|
2
|
25.0
|
6
|
75.0
|
1.000
|
0.435
|
|
Expired
|
12
|
6
|
50.0
|
6
|
50.0
| |
12
|
2
|
16.7
|
10
|
83.3
| |
0.193
|
|
Type of infection
|
Primary
|
1
|
0
|
0.0
|
1
|
100.0
|
1.000
|
5
|
2
|
0.0
|
3
|
100.0
|
1.000
| |
|
Secondary
|
49
|
9
|
18.4
|
40
|
81.6
| |
15
|
4
|
21.1
|
11
|
78.9
| |
1.000
|
|
Secondary infection (multiple)
|
Total
|
49
|
19
| |
30
| | |
15
|
5
| |
10
| | | |
|
Respiratory tract
|
30
|
10
|
33.3
|
20
|
66.7
|
0.326
|
3
|
1
|
33.3
|
2
|
66.7
|
0.370
|
1.000
|
|
Urinary tract
|
12
|
2
|
16.7
|
10
|
83.3
|
0.095
|
6
|
1
| |
5
| |
0.023
|
1.000
|
|
Catheter-related
|
2
|
0
|
0.0
|
2
|
100.0
|
0.515
|
0
|
0
|
0.0
|
0
|
100.0
|
1.000
| |
|
Intra-abdominal infection
|
9
|
2
|
22.2
|
7
|
77.8
|
0.451
|
6
|
0
|
0.0
|
6
|
100.0
|
0.474
|
1.000
|
|
CNS infection
|
3
|
1
|
33.3
|
2
|
66.7
|
1.000
|
0
|
0
|
0.0
|
0
|
0.0
| | |
| |
Others
|
3
|
1
|
33.3
|
2
|
66.7
|
1.000
|
0
|
0
|
0.0
|
0
|
00
|
0.474
|
1.000
|
- P-value by chi-squared test or Fisher’s exact test when appropriate.
